Project Number 5R21AG027468-02 Agency/Funding Organization NIA Funding Year 2008 View Full Project Details for NO/CGMP/CREB PATHWAY ENHANCERS FOR TREATMENT OF ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ARANCIO, OTTAVIO Principal Investigator First Name OTTAVIO Principal Investigator Last Name ARANCIO Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-06-261: Grants for Alzheimer's Disease Drug Discovery (R21) FY Overall Cost $201,170 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Patent Phosphodiesterase inhibitors and uses thereof Phosphodiesterase inhibitors and uses thereof
